These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5596251)

  • 1. [On the prognostic value of several hepatic function tests in liver cirrhosis].
    Zannini L; Palleschi A
    Friuli Med; 1967; 22(4):895-910. PubMed ID: 5596251
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of liver function tests in tuberculosis of liver and cirrhosis of liver.
    Chandrasekhar PH; Rolston DD; Pulimood BM
    J Assoc Physicians India; 1979 May; 27(5):391-4. PubMed ID: 528491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laboratory tests in therapeutic management and prognostic judgement of hepatic cirrhosis. Statistical analysis of the problem].
    Cairella M; Coppi R; D'Arcangelo E
    Clin Ter; 1970 Jan; 52(1):17-53. PubMed ID: 5525553
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the serum BG(P-B) value from glucagon loading test in assessing liver function of cirrhosis patients].
    Wu BF; Lin LL; Hu PJ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):186. PubMed ID: 12681076
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical investigation of Q-T prolongation in hepatic cirrhosis].
    Li L; Liu HR; Shu JL; Xi XP; Wang Y
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2717-8. PubMed ID: 18167253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
    Everson GT; Shiffman ML; Morgan TR; Hoefs JC; Sterling RK; Wagner DA; Kulig CC; Curto TM; Wright EC;
    Aliment Pharmacol Ther; 2008 May; 27(9):798-809. PubMed ID: 18266997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
    Nyblom H; Björnsson E; Simrén M; Aldenborg F; Almer S; Olsson R
    Liver Int; 2006 Sep; 26(7):840-5. PubMed ID: 16911467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis.
    Lindskov J
    Acta Med Scand; 1982; 212(5):303-8. PubMed ID: 7180580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of liver function for patients with cirrhosis by 13C-methacetin breath test compared with Child-Pugh score and routine liver function tests.
    Liu YX; Huang LY; Wu CR; Cui J
    Chin Med J (Engl); 2006 Sep; 119(18):1563-6. PubMed ID: 16996011
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic effects of calcium-2,2'-disulfohexanoate in hepatic cirrhosis].
    Cangiano C; Angelico M; Rossi Fanelli F
    Clin Ter; 1978 Aug; 86(4):337-53. PubMed ID: 737963
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum T3 and reverse T3 levels in hepatic cirrhosis: relation to hepatocellular damage and normalization on improvement in liver dysfunction.
    Kabadi UM; Premachandra BN
    Am J Gastroenterol; 1983 Nov; 78(11):750-5. PubMed ID: 6637968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
    Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
    Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
    Tietge UJ; Böker KH; Manns MP; Bahr MJ
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
    Giannini E; Botta F; Borro P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Mamone M; Testa R
    Am J Gastroenterol; 2003 Nov; 98(11):2516-20. PubMed ID: 14638357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of intestinal absorption in patients with hepatic cirrhosis].
    Cantor DS; Kravetz D; Paz RA; Colombato L
    Medicina (B Aires); 1972; 32(6):543-8. PubMed ID: 4663250
    [No Abstract]   [Full Text] [Related]  

  • 17. A correlative study of serum copper level and liver function test and its diagnostic and prognostic significance in cases of cirrhosis of liver.
    Sharma SK; Singh R; Gupta MC; Lahiri VL; Patney NL; Prakash V; Maheshwari BB; Kulshrestha A; Tyagi A
    J Assoc Physicians India; 1985 Nov; 33(11):710-1. PubMed ID: 4093382
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver damage in obese patients.
    Del Gaudio A; Boschi L; Del Gaudio GA; Mastrangelo L; Munari D
    Obes Surg; 2002 Dec; 12(6):802-4. PubMed ID: 12568185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent prognostic factors in patients with liver cirrhosis.
    Piekarska A; Zboinska J; Szymczak W; Kuydowicz J
    Hepatogastroenterology; 2008; 55(84):1034-40. PubMed ID: 18705324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On senile hepatic cirrhosis].
    Cicala V
    G Gerontol; 1968 Mar; 16(3):204-10. PubMed ID: 5715952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.